Recommendations Financial News

₹59,608 per 10 grams around 10 am. Also Read: IRM Energy IPO: Check GMP today, subscription status, should you subscribe? (Exciting news! Mint is now on WhatsApp Channels. Subscribe today by clicking the link and stay updated with the latest financial insights! Click here!) Manoj Kumar Jain of Prithvifinmart Commodity Research expects gold and silver to remain volatile this week.

A new report says that crash and fatality rates among drivers under 21 have fallen dramatically in the U.S. during the past 20 years but young drivers are still the riskiest group behind the wheel

Kunal Vora, Director, Head of India Equity Research, BNP Paribas, is confident on a long-term theme called affluent India. The income tax data which came out in recent months show that affluent India – the top 10% of the income earners – is doing really well and some of the stocks which BNP Paribas is recommending are coming from that theme.

₹480 to ₹505 per equity share. IRM Energy IPO is completely a fresh issue of 1.08 crore equity shares of face value of ₹10 each and there is no offer for sale (OFS) component. At the upper end of the price band, the company plans to raise ₹545.40 crore from the public issue.

₹2,123.6 crore, registering a growth of 32.5 per cent from ₹1,603.29 crore in the same quarter last year. Net interest income (NII), which is the difference between interest earned and interest expended, during Q1FY24 increased 18 per cent to ₹5,862.5 crore from ₹4,125.3 crore, YoY. Let's take a look at what experts and top brokerage firms expect from IndusInd Bank's Q2FY24 scorecard.

Day trading guide for today: Key equity indices the Sensex and the Nifty 50 ended with gains in the previous session, snapping their three-day losing run, on widespread buying across various sectors amid positive global cues. While the Israel-Hamas conflict endures and concerns about its potential spread to other nations persist, investors appear to have shifted their attention towards corporate earnings and macroeconomic indicators. Nifty 50 index closed the day at 19,811.50, up 80 points, or 0.40 per cent.

Buy or sell stocks for today: Key benchmark indices - Sensex and the Nifty 50 - ended with gains on October 18, snapping their three days of losses on widespread buying across various sectors amid positive global cues. Nifty 50 yesterday opened at 19,843.20 against the previous close of 19,731.75. The index closed at 19,811.50, up 80 points, or 0.40 percent.

Origin Energy chairman Scott Perkins has told shareholders that the board took into account the improved outlook for the business when agreeing to an $18.7 billion takeover offer from two North American suitors.

A Department of Labor official said the agency’s next attempt at setting investment advice standards for retirement accounts will not just be a rehash of previous fiduciary rules.

Federal authorities say a broken rail caused a train derailment that collapsed a bridge over a Colorado highway

Dr Reddy's Laboratories has got a go-head from the Subject Expert Committee (SEC) under India's drug regulatory authority to conduct a bioequivalence study required to establish the safety and efficacy of the blockbuster weight loss drug Semaglutide on the Indian population. Dr Reddy's had approached the SEC in April with a proposal for manufacture and marketing of synthetically developed Semaglutide injection 2mg/1.5ml (1.34mg/ml) and Semaglutide injection 4mg/3ml (1.34mg/ml). The company had also sought a waiver of BE study and Phase III clinical trial. However, the SEC recommended the company conduct a bioequivalence study and asked it to submit the protocol for the same for further review. At a SEC meet on September 29, «the committee recommended for grant of permission to conduct bioequivalence study as per protocol presented by the firm,» as per the minutes of the meeting. The committee said the Phase-III clinical trial waiver can be considered based on the review of the bioequivalence study report by the committee, it further said. ET has seen the minutes of the meeting. If all goes as per plan, the injection could be launched in a year, an industry insider said on the condition of anonymity. The drugs — Wegovy and Ozempic — that share the same ingredient, Semaglutide, are all the rage ever since Elon Musk tweeted about it.

GQ magazine, actor Timothée Chalamet, best known for his role in "Dune," opened up about an inspiring encounter with Hollywood legend Tom Cruise. Following their meeting during the production of «Dune,» Cruise sent Chalamet an email offering advice and encouragement. Cruise's email contained a list of stunt trainers, motorcycle coaches, and more, as he referenced the traditional approach to training in Old Hollywood.

Quarterly earnings reports have begun to pour in on a positive note, especially for the big banks. In fact, based on the performance of the companies that have already reported so far, the current trend indicates that we have already bottomed out in the previous quarter.

Also Read- NALCO, NMDC share prices gain as nod for royalty rates for Lithium, REEs lift prospects Going ahead, commentaries from the companies will be critical as the price-cost effect outlook (particularly for ferrous) is likely to take center stage, said analysts at ICICI Securities. Their top picks include Jindal Steel and Power Ltd (JSPL), Jindal Stainless, and Shyam Metalics.

We don’t support this browser anymore. This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

We don’t support this browser anymore. This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Dolly Khanna portfolio: Shares of Talbros Automotive Components Ltd have delivered stellar return to its shareholders in new financial year 2023-24. This Dolly Khanna stock has surged from around ₹390 to ₹1,140 apiece levels on NSE, delivering to the tune of 200 per cent in last six and half months. However, it seems that Chennai-based investor Dolly Khanna is still finding steam in this multibagger stock.

Hero MotoCorp (HMCL) as the 'Choice ka Techno Funda' pick. The brokerage recommends buying Hero Moto in cash at ₹3,170 and add up to ₹3,080 for a target price of ₹3,620 for a duration of 1-3 months. This target indicates an upside of 14.5 percent.

Indian stocks, which has delivered stellar return to shareholders in YTD. This Indian auto major has backing of various mutual funds and state-owned insurer Life Insurance Corporation (LIC) of India.

₹20,000. The AEPS method serves as a user-friendly method for individuals to reach their bank accounts, particularly beneficial for those lacking smartphones or internet connectivity. Even if you don’t intend to use AEPS, there remains a chance that malicious individuals may exploit your data to infiltrate your accounts.

midcap stocks achieved historic milestones by reaching new all-time highs on October 17. These remarkable performances highlight the strength and growth potential of these companies, offering investors a diverse range of opportunities in both the large and midcap segments. The data was sourced from StockEdge at 1:15 p.m., and the updates from the real-time data could come with a lag. The below data also pertains only to the time at which it was taken.